These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7202951)

  • 1. Terminal hepatic failure following a small dose of sulfamethoxazole-trimethoprim.
    Ransohoff DF; Jacobs G
    Gastroenterology; 1981 Apr; 80(4):816-9. PubMed ID: 7202951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimethoprim-sulfamethoxazole-induced cholestasis.
    Abi-Mansur P; Ardiaca MC; Allam C; Shamma'a M
    Am J Gastroenterol; 1981 Oct; 76(4):356-9. PubMed ID: 7325149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fatal agranulocytosis and toxic liver damage after use of trimethoprim-sulfamethoxazole].
    Haaverstad R; Kannelønning KS
    Tidsskr Nor Laegeforen; 1984 Apr; 104(10-11):741-2. PubMed ID: 6719414
    [No Abstract]   [Full Text] [Related]  

  • 4. Trimethoprim-sulfamethoxazole-associated hepatotoxicity - part of a hypersensitivity syndrome.
    Mainra RR; Card SE
    Can J Clin Pharmacol; 2003; 10(4):175-8. PubMed ID: 14712321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute fulminant hepatic failure in a woman treated with phenytoin and trimethoprim-sulfamethoxazole.
    Ilario MJ; Ruiz JE; Axiotis CA
    Arch Pathol Lab Med; 2000 Dec; 124(12):1800-3. PubMed ID: 11100060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamivudine-stavudine-induced liver failure in hepatitis B cirrhosis.
    Schiano TD; Lissoos TW; Ahmed A; Siano C; Zaitman D; Cohn G; Ehrenpreis ED
    Am J Gastroenterol; 1997 Sep; 92(9):1563-4. PubMed ID: 9317091
    [No Abstract]   [Full Text] [Related]  

  • 7. Trimethoprim-sulfamethoxazole: hyperkalemia is an important complication regardless of dose.
    Perazella MA; Mahnensmith RL
    Clin Nephrol; 1996 Sep; 46(3):187-92. PubMed ID: 8879854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of desensitization with sulfamethoxazole and trimethoprim in 48 previously hypersensitive patients infected with human immunodeficiency virus.
    Caumes E; Guermonprez G; Lecomte C; Katlama C; Bricaire F
    Arch Dermatol; 1997 Apr; 133(4):465-9. PubMed ID: 9126010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfonamide hepatic injury. Review of the literature and report of a case due to sulfamethoxazole.
    Dujovne CA; Chan CH; Zimmerman HJ
    N Engl J Med; 1967 Oct; 277(15):785-8. PubMed ID: 6046676
    [No Abstract]   [Full Text] [Related]  

  • 10. Trimethoprim-sulfamethoxazole-induced intrahepatic cholestasis.
    Nair SS; Kaplan JM; Levine LH; Geraci K
    Ann Intern Med; 1980 Apr; 92(4):511-2. PubMed ID: 7362156
    [No Abstract]   [Full Text] [Related]  

  • 11. Acquired resistance to trimethoprim-sulfamethoxazole during Whipple disease and expression of the causative target gene.
    Bakkali N; Fenollar F; Biswas S; Rolain JM; Raoult D
    J Infect Dis; 2008 Jul; 198(1):101-8. PubMed ID: 18500934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QT prolongation and paroxysmal ventricular tachycardia occurring during fever following trimethoprim-sulfamethoxazole administration.
    Wiener I; Rubin DA; Martinez E; Postman J; Herman MV
    Mt Sinai J Med; 1981; 48(1):53-5. PubMed ID: 6970886
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma levels of trimethoprim and sulfonamide after administration of trimethoprim-sulfamethoxazole and trimethoprim-sulfamoxole.
    Gupta KC; Desai NK; Paul T; Sheth UK
    Int J Clin Pharmacol Ther Toxicol; 1980 Dec; 18(12):536-7. PubMed ID: 7228448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfamethoxazole-induced hepatic injury.
    Steinbrecher UP; Mishkin S
    Dig Dis Sci; 1981 Aug; 26(8):756-9. PubMed ID: 7261840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of lamivudine administered alone and with trimethoprim-sulfamethoxazole.
    Moore KH; Yuen GJ; Raasch RH; Eron JJ; Martin D; Mydlow PK; Hussey EK
    Clin Pharmacol Ther; 1996 May; 59(5):550-8. PubMed ID: 8646826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omeprazole-induced hepatotoxicity? A case report.
    Christe C; Stoller R; Vogt N
    Pharmacoepidemiol Drug Saf; 1998 Aug; 7 Suppl 1():S41-4. PubMed ID: 15073958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe hypoglycemia associated with use of trimethoprim/sulfamethoxazole in a patient with chronic renal insufficiency.
    Rosini JM; Martinez E; Jain R
    Ann Pharmacother; 2008 Apr; 42(4):593-4. PubMed ID: 18364403
    [No Abstract]   [Full Text] [Related]  

  • 18. Trimethoprim-sulfamethoxazole induced recurrent aseptic meningitis.
    Meng MV; St Lezin M
    J Urol; 2000 Nov; 164(5):1664-5. PubMed ID: 11025739
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis.
    Radha Krishna Y; Saraswat VA; Das K; Himanshu G; Yachha SK; Aggarwal R; Choudhuri G
    Liver Int; 2009 Mar; 29(3):392-8. PubMed ID: 19267864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aplastic anemia after transplantation for non-A, non-B, non-C fulminant hepatic failure: case report and review of the literature.
    Itterbeek P; Vandenberghe P; Nevens F; Fevery J; Aerts R; Yap SH; Demuynck H; Fourneau I; Koshiba T; Emonds MP; Roskams T; Boogaerts M; Pirenne J
    Transpl Int; 2002 Mar; 15(2-3):117-23. PubMed ID: 11935168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.